SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Umax Group Corp (OTCMKTS:UMAX) was a massive mover during Tuesday’s trading session. The stock surged by close to 99% on the back of high volumes, which were 7 times the daily average. The stock has been in a downtrend and seems to have formed a strong bottom near levels of $0.0007. The stock has witnessed strong buying interest over the last few trading sessions. The index for relative strength has given a buy signal, which is a huge positive. The stock currently trades above its 50-day moving average. Traders see the stock heading to levels of $0.0021 in the near term.

UMAX..J

Umax Group Corp (OTCMKTS:UMAX) is delighted to announce the appointment of new public relations officer to execute all the projects and strengthen its public presence in an effective manner. As per the reports, Robert Haltom will be the new PR officer of Umax Group.

Insights On The Matter

Haltom is one of the most experienced and skilled executives in the industry in today’s time. His expertise in handling organizational issues and company management can add value to Umax Group in a significant manner. Talking about his roles and responsibilities, one of the company spokespersons said that Haltom will look after new revenue generating opportunities with respect to a possible acquisition or merger that can bring positive results in the future.

As soon as he comes across any such opportunity, he will need to negotiate terms and conditions, prepare documentation and present the same in front of the board of directors. The senior management of the company is delighted to have him onboard. According to Ian Dixon, Chief Executive Officer, Umax Group, the appointment of Robert Haltom is one of the best decisions that board has taken lately. With the kind of skills and expertise he possesses, everyone at Umax is confident that he will prove to be a great asset to the company.

Haltom has founded many businesses over the past 22 years. His experience as a founder, CEO and business leader in startup vertical makes him the best choice for this role. He studied communications at Brigham young University, but his inclination towards human resource subject was something that sat him apart from others. Haltom founded his first company named Associated Pharmaceutical Group while studying.

Thereafter, he went on to find many companies and built businesses from scratch, which developed him into one of the finest business leaders in the industry. The senior management of Umax Group is confident that Haltom will help the company climb desired success ladders in the coming months.